To evaluate the safety, tolerability, and efficacy of repeated oral doses of ENT-01 for up to 25 days in subjects with Parkinson’s Disease-related constipation.
Patients will be randomized to active investigational treatment or placebo, and followed for approximately 70 days. Patients will have 6 visits to the clinic.